With over 25 years of experience in mouse genetics, Cat Lutz has focused her research efforts on patient organizations and families diagnosed with rare diseases. She serves as the Principal Investigator of multiple NIH sponsored programs including the Center for Precision Genetics, The Somatic Cell Genome Editing Center, and Mouse Mutant Research and Resource Center. As a neuroscientist by training, she has worked on models of the central nervous system such as Spinal Muscular Atrophy, Amyotrophic Lateral Sclerosis and Friedreich’s Ataxia. Lutz was awarded with a Rare Impact Award by the National Organization for Rare Disorders in 2021.
Anil Akturk
Ph.D.
Study Director
Driving scientific innovation to transform rare disease research into therapeutic breakthroughs
Meet Anil
Amy E. Clipperton-Allen
Ph.D.
Senior Manager, Behavioral Phenotyping
Leads optimization and development of high-quality, standardized behavioral phenotyping and behavioral training to enable model characterization and preclinical therapeutic testing.
Meet Amy
Dana Layo-Carris
Ph.D.
Study Director
Directs characterization and IND enabling therapeutic programs for rare disease research. Head of New Patient Program.
Meet Dana
Sarah Lecordier
Ph.D.
Associate Study Director
Mouse characterization and preclinical development for rare disorders.
Meet Sarah
Aric Madayag
Ph.D.
Study Director
Preclinical mouse model characterization and development of novel therapeutics for rare diseases.
Meet Aric
Jenny Morgenweck
Ph.D
Director, Operations - Rare Disease Translational Center
Leads a team focused on ensuring seamless day-to-day and strategic operations. Our work streamlines processes to accelerate the generation of high-quality pre-IND data for rare disease treatments.
Meet Jenny
Vincent Pons
Ph.D, M.B.A
Study Director
With expertise in neurodevelopmental syndromes, skeletal defects and more, Vincent helps foundations and external collaborators achieve their goals to cure rare diseases.
Meet Vincent
Maximiliano Presa
Ph.D.
Study Director
Development and molecular characterization of new mice models for human diseases. Utilizing mice models as a platform for pre-clinical evaluation of new therapies.
Meet Maximiliano
Lorin Roiphe
Ph.D.
Senior Program Manager, RDTC Business Portfolio Management
Business Support for the Rare Disease Translational Center
Meet Lorin
Jennifer SanMiguel
Ph.D.
Senior Study Director
Directs translational programs from novel model characterization through IND-enabling therapeutic studies.
Meet Jennifer
Matthew Simon
Ph.D.
Senior Study Director, Lead Scientist
Lead scientist in the rare disease neurodevelopmental program. Coordinates with patient advocacy groups and research partners to develop research programs to characterize new mouse models for genetic diseases and explore therapeutic testing.
Meet Matthew
Rebecca Smith
M.S., CGC
Clinical Research Project Manager
With a background in clinical human genetics, I aim to bridge the needs of rare disease families and foundations with the scientific capabilities at JAX.
Meet Rebecca
Markus Terrey
Ph.D.
Study Director
Investigation and pre-clinical testing for rare neurological diseases.
Meet Markus
Konstantinos Vanezis
Ph.D.
Scientific Investigator - ASO development
Leads the design, development, and delivery of oligonucleotide therapeutics for rare genetic diseases.
Meet Konstantinos
Louisa Wang
Ph.D.
Scientific Investigator - Gene Editing Therapeutics
Lead the design, development, and delivery of gene editing/gene therapy medicines for the treatment of rare diseases.
Meet Louisa